生物
细胞代谢
犬尿氨酸
糖酵解
FOXP3型
细胞生物学
转录组
代谢途径
危重病
犬尿氨酸途径
免疫学
免疫系统
细胞代谢
代谢控制分析
吲哚胺2,3-双加氧酶
细胞
线粒体
新陈代谢
适应(眼睛)
T细胞
氧代谢
平衡
炎症
败血症
表型
调节性T细胞
促炎细胞因子
细胞因子
癌症研究
活性氧
生物能学
提吉特
病态的
作者
Matthew T. Stier,Allison E. Sewell,E.L. Mwizerwa,Chooi Ying Sim,Steve Tanner,C. Mark Nichols,Heather H. Durai,Erin Q. Jennings,Paul Lindau,Erin M. Wilfong,S. Obeidalla,V Eric Kerchberger,Dawn C. Newcomb,Julie A. Bastarache,Lorraine B. Ware,Jeffrey C. Rathmell
标识
DOI:10.1038/s41590-025-02390-6
摘要
Abstract Metabolic and immunologic dysfunction, including pathological CD4 + T cell immunosuppression, are archetypal in critical illness, but whether these factors are mechanistically linked remains incompletely defined. Here we characterized the metabolic properties of human CD4 + T cells from critically ill patients with and without sepsis and healthy adults. CD4 + T cells in critical illness showed subset-specific metabolic plasticity, with regulatory T (T reg ) cells preferentially acquiring glycolytic capacity that associated with sustained cellular fitness and worsened clinical illness. Adapted T reg cells were more metabolically flexible and stabilized suppressive markers FOXP3 and TIGIT under mitochondrial stress. Single-cell transcriptomics suggested reactive oxygen species (ROS) and kynurenine metabolism as drivers of T reg cell remodeling. Subsequent inhibition of ROS and kynurenine metabolism attenuated glycolytic adaptation and suppressive rewiring, respectively, in T reg cells. These findings indicate that metabolic dysfunction was a contributor to CD4 + T cell remodeling in critical illness and suggest avenues to restore effective immunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI